CH1handouts_drug_development - Biotechnology and health...

Info iconThis preview shows pages 1–3. Sign up to view the full content.

View Full Document Right Arrow Icon
1 MPET: Drug development Biotechnology and health diagnostics therapy : products drug development: process MPET: Drug development Biotechnology and drug development search for pathogenic mechanisms of disease target identification and validation screening for molecules MPET: Drug development Drug development direct identification: insulin, erythropoietin serendipity: penicillin rational screening MPET: Drug development Drug development: phases 1. Discovery Research 2. Preclinical testing 3. Clinical testing 4. Registration and marketing 5. Post-marketing surveillance MPET: Drug development Discovery Research (rational screening) Deliverable= isolation or synthesis of a new substance with biological activity and potential therapeutic value 1. Target identification 2. Target validation 3. Assay development 4. High throughput screening and lead-identification 5. Lead optimization/candidate selection MPET: Drug development Target identification molecule to which the drug is aimed (receptor) quantity or activation changes and correlates with disease identified by direct analysis or “omics” drugable target
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
2 MPET: Drug development
Background image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 05/28/2010 for the course WE BIBI000000 taught by Professor Johangrooten during the Spring '10 term at Ghent University.

Page1 / 4

CH1handouts_drug_development - Biotechnology and health...

This preview shows document pages 1 - 3. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online